1 |
Bimonte S, Crispo A, Amore A, Celentano E, Cuomo A, Cascella M. Potential antiviral drugs for SARS-Cov-2 treatment: Preclinical findings and ongoing clinical research. In Vivo 2020;34(3 Suppl):1597-1602.
DOI
|
2 |
Gammoh NZ, Rink L. Zinc in infection and inflammation. Nutrients 2017;9(6):624.
DOI
|
3 |
World Health Organization. Coronavirus disease (COVID-19) pandemic. Available from https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed November 24, 2020.
|
4 |
Frontera JA, Rahimian JO, Yaghi S, et al. Treatment with zinc is associated with reduced in-hospital mortality among COVID-19 patients: a multi-center cohort study. Res Sq [Preprint] 2020:rs.3.rs-94509.
|
5 |
Read SA, Obeid S, Ahlenstiel C, Ahlenstiel G. The role of zinc in antiviral immunity. Adv Nutr 2019;10(4):696-710.
DOI
|
6 |
Wessels I, Maywald M, Rink L. Zinc as a gatekeeper of immune function. Nutrients 2017;9(12):1286.
DOI
|
7 |
Acevedo-Murillo JA, Garcia Leon ML, Firo-Reyes V, Santiago-Cordova JL, Gonzalez-Rodriguez AP, Wong-Chew RM. Zinc supplementation promotes a Th1 response and improves clinical symptoms in fewer hours in children with pneumonia younger than 5 years old. a randomized controlled clinical trial. Front Pediatr 2019;7:431.
DOI
|
8 |
Barnett JB, Hamer DH, Meydani SN. Low zinc status: a new risk factor for pneumonia in the elderly? Nutr Rev 2010;68(1):30-7.
DOI
|
9 |
Lassi ZS, Moin A, Bhutta ZA. Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months. Cochrane Database Syst Rev 2016;12(12):CD005978.
|
10 |
Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev 2013;(6):CD001364.
|
11 |
te Velthuis AJ, van den Worm SH, Sims AC, Baric RS, Snijder EJ, van Hemert MJ. Zn(2+) inhibits coronavirus and arterivirus RNA polymerase activity in vitro and zinc ionophores block the replication of these viruses in cell culture. PLoS Pathog 2010;6(11):e1001176.
DOI
|
12 |
Bobat R, Coovadia H, Stephen C, et al. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet 2005; 366(9500):1862-7.
DOI
|
13 |
Zeng L, Zhang L. Efficacy and safety of zinc supplementation for adults, children and pregnant women with HIV infection: systematic review. Trop Med Int Health 2011;16(12):1474-82.
DOI
|
14 |
Xue J, Moyer A, Peng B, Wu J, Hannafon BN, Ding WQ. Chloroquine is a zinc ionophore. PLoS One 2014;9(10):e109180.
DOI
|
15 |
Higgins JPT TJ, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for Systematic Reviews of Interventions version 6.1.0 [updated September 2020]. Available from www.training.cochrane.org/handbook. Accessed January 8, 2021.
|
16 |
Prasad AS. Discovery of zinc for human health and biomarkers of zinc deficiency. Molecular, Genetic, and Nutritional Aspects of Major and Trace Minerals 2017;241-260.
|
17 |
Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA GROUP. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ 2009;339:b2535.
DOI
|
18 |
Higgins JP, Altman DG, Gotzsche PC, et al. The cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
DOI
|
19 |
Wells GA, Shea B, O'Connell Da, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.2011. Available from http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed February 14, 2021.
|
20 |
Lim SM, Shin ES, Lee SH, et al. Tools for assessing quality and risk of bias by levels of evidence. J Korean Med Assoc 2011; 54(4): 419-29.
DOI
|
21 |
Yao JS, Paguio JA, Dee EC, et al. The minimal effect of zinc on the survival of hospitalized patients with COVID-19: an observational study. Chest 2021;159(1):108-11.
DOI
|
22 |
Carlucci PM, Ahuja T, Petrilli C, Rajagopalan H, Jones S, Rahimian J. Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients. J Med Microbiol 2020;69(10):1228-34.
DOI
|
23 |
Abd-Elsalam S, Soliman S, Esmail ES, et al. Do zinc supplements enhance the clinical efficacy of Hydroxychloroquine?: a randomized, multicenter trial. Biol Trace Elem Res 2020:1-5.
|
24 |
Gao YD, Ding M, Dong X, et al. Risk factors for severe and critically ill COVID-19 patients:a review. Allergy 2021;76(2):428-55.
DOI
|
25 |
Hemila H. Zinc lozenges may shorten the duration of colds: a systematic review. Open Respir Med J 2011;5:51-58.
DOI
|
26 |
Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res 2018;27(6):1785-1805.
DOI
|
27 |
Awotiwon AA, Oduwole O, Sinha A, Okwundu CI. Zinc supplementation for the treatment of measles in children. Cochrane Database Syst Rev 2017;6(6):CD011177.
|
28 |
Shittu MO, Afolami OI. Improving the efficacy of chloroquine and hydroxychloroquine against SARS-CoV-2 may require zinc additives - a better synergy for future COVID-19 clinical trials. Infez Med 2020;28(2):192-97.
|
29 |
Wang L, Song Y. Efficacy of zinc given as an adjunct to the treatment of severe pneumonia: a meta-analysis of randomized, double-blind and placebo-controlled trials. Clin Respir J 2018;12(3):857-64.
DOI
|